{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:48:18Z","timestamp":1791658098790,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":188,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.prdoa.2026.100482","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:02:46Z","timestamp":1783602166000},"page":"100482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Access to Parkinson's disease treatments in the Middle East: a multi-national survey of availability, affordability, and utilization patterns"],"prefix":"10.1016","volume":"15","author":[{"given":"Mehri","family":"Salari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakiyah","family":"Aldaajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Etemadifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"G\u00fcltekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Alfwaress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudassar Iqbal","family":"Arain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6060-7395","authenticated-orcid":false,"given":"Sevim","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prdoa.2026.100482_bb0005","doi-asserted-by":"crossref","first-page":"1498756","DOI":"10.3389\/fnagi.2024.1498756","article-title":"Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021","volume":"16","author":"Luo","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"10423","key":"10.1016\/j.prdoa.2026.100482_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson\u2019s disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100482_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12889-023-15018-x","article-title":"The burden of Parkinson\u2019s disease in the Middle East and North Africa region, 1990-2019: results from the global burden of disease study 2019","volume":"23","author":"Safiri","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.prdoa.2026.100482_bb0020","author":"Key"},{"issue":"1","key":"10.1016\/j.prdoa.2026.100482_bb0025","article-title":"Health disparities in the Middle East: representative analysis of the region","volume":"4","author":"Assa\u2019ad","year":"2025","journal-title":"J. Allergy Clin. Immunol. Glob."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100482_bb0030","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3233\/JPD-213006","article-title":"Surveying global availability of Parkinson\u2019s disease treatment","volume":"12","author":"Goh","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100482_bb0035","first-page":"1","article-title":"The impact of the socioeconomic factor on Parkinson\u2019s disease medication adherence: a scoping review","volume":"82","author":"Gil","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"issue":"2","key":"10.1016\/j.prdoa.2026.100482_bb0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JPD-191751","article-title":"Parkinson\u2019s disease in the Middle East, North Africa, and South Asia: consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East","volume":"10","author":"Khalil","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.prdoa.2026.100482_bb0045","series-title":"Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022\u20132031","author":"Organization WH","year":"2023"},{"issue":"20","key":"10.1016\/j.prdoa.2026.100482_bb0050","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.prdoa.2026.100482_bb0055","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2022"},{"issue":"7","key":"10.1016\/j.prdoa.2026.100482_bb0060","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JPD-230114","article-title":"Burden of Parkinsonism and Parkinson\u2019s disease on health service use and outcomes in Latin America","volume":"13","author":"Kim","year":"2023","journal-title":"J. Parkinsons Dis."},{"issue":"10","key":"10.1016\/j.prdoa.2026.100482_bb0065","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/mds.28669","article-title":"Availability of therapies and Services for Parkinson\u2019s disease in Africa: a continent-wide survey","volume":"36","author":"Hamid","year":"2021","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.prdoa.2026.100482_bb0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100482_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/hex.70380","article-title":"Barriers and facilitators to accessing healthcare for people with Parkinson\u2019s disease in Latin America: a qualitative study","volume":"28","author":"Jeyachandran","year":"2025","journal-title":"Health Expect."},{"issue":"4","key":"10.1016\/j.prdoa.2026.100482_bb0080","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/mdc3.12294","article-title":"The accessibility of Parkinson\u2019s disease medication in Kenya: results of a national survey","volume":"3","author":"Mokaya","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"1","key":"10.1016\/j.prdoa.2026.100482_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mdc3.12682","article-title":"A Nationwide survey of Parkinson\u2019s disease medicines availability and affordability in Nigeria","volume":"6","author":"Okubadejo","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"10","key":"10.1016\/j.prdoa.2026.100482_bb0090","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2471\/BLT.25.293460","article-title":"Parkinson disease treatments on national essential medicines lists, African region","volume":"103","author":"Fothergill-Misbah","year":"2025","journal-title":"Bull. World Health Organ."},{"issue":"11","key":"10.1016\/j.prdoa.2026.100482_bb0095","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/mdc3.14192","article-title":"Access to medicines for Parkinson\u2019s disease in Kenya: a qualitative exploration","volume":"11","author":"Fothergill-Misbah","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"3","key":"10.1016\/j.prdoa.2026.100482_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/jep.14169","article-title":"Structure and process of Parkinson\u2019s disease rehabilitation in the southern sector of Ghana: a cross-sectional survey","volume":"31","author":"Agoriwo","year":"2025","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.prdoa.2026.100482_bb0105","article-title":"Parkinson\u2019s disease in central Asian and Transcaucasian countries: a review of epidemiology, genetics, clinical characteristics, and access to care","volume":"2019","author":"Kaiyrzhanov","year":"2019","journal-title":"Parkinsons Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.prdoa.2026.100482_bb0110","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1468-1331.2005.01197.x","article-title":"Cost of Parkinson\u2019s disease in Europe","volume":"12","author":"Lindgren","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.prdoa.2026.100482_bb0115","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1016\/j.wneu.2018.02.023","article-title":"Movement disorders and deep brain stimulation in the Middle East","volume":"113","author":"Siddiqui","year":"2018","journal-title":"World Neurosurg."},{"key":"10.1016\/j.prdoa.2026.100482_bb0120","article-title":"Patterns and determinants of prescribing for Parkinson\u2019s disease: a systematic literature review","volume":"2019","author":"Orayj","year":"2019","journal-title":"Parkinsons Dis."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112526000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112526000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:49:50Z","timestamp":1791654590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112526000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":24,"alternative-id":["S2590112526000629"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2026.100482","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Access to Parkinson's disease treatments in the Middle East: a multi-national survey of availability, affordability, and utilization patterns","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2026.100482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100482"}}